Survey samples life scientists' views on 'dual use' research and bioterrorismFebruary 06, 2009Some respondents already taking action to avert misuse of research WASHINGTON -- Rapid advances in the biological sciences over the last several decades have yielded great benefits such as medical therapies and vaccines. But some of these same scientific advances could also be used for malicious purposes, a threat that has become more salient to the science and policy communities since the terrorist attacks of 2001. The National Research Council and the American Association for the Advancement of Science (AAAS) surveyed a sample of AAAS members in the life sciences to assess their awareness of and attitudes toward such "dual-use" research - studies undertaken for beneficial purposes that could also have harmful applications such as bioterrorism. The survey also explored actions the scientists might support to reduce the risk of misuse of research, as well as steps that scientists may already be taking in response to these concerns. The results of the survey, conducted in 2007, are summarized in a new report from the Research Council, which includes recommendations for next steps. The survey yielded some of the first empirical data on U.S. life scientists' views about biosecurity and the potential misuse of legitimate scientific research. The survey results offer insights and generate hypotheses that can be tested in future efforts, said the committee that wrote the report. However, a low response rate and uncertainties about whether the sample reflects the broader life sciences community limit the ability to generalize from the responses about the full U.S. life sciences community. Nevertheless, even with this limitation, the survey results are useful and informative, noted the committee. The results suggest that survey respondents perceive a potential but not overwhelming risk of a bioterror attack in the next five years, a risk they believe is greater outside the U.S. Most respondents do not believe it is likely that dual-use knowledge, tools, or techniques will facilitate a bioterror attack in that time period. Survey results also indicate that some respondents -- more than the committee had expected -- have been so concerned about dual-use issues that they have already taken action to try to avert misuse of research in the life sciences, even in the absence of guidelines or government restrictions. Some respondents reported that they had broken collaborations, not conducted some research projects, or not communicated research results. Many of respondents' precautionary actions were taken during design, collaboration, and initial communication stages of research, before reaching the publication stage, the report notes. Of particular interest and concern to the committee, a few respondents offered comments about foreigners as potential security risks, which may be reflected in the reported avoidance of some collaborations. "The fact that some scientists are changing their research activities may indicate that the life sciences community is responsibly responding to reduce the risk of misuse of science," said committee chair Ronald Atlas, professor of biology and public health at the University of Louisville. "But it is also possible that some scientists are overreacting to the perceived threat, for example by breaking collaborations and excluding foreigners from their laboratories. Our committee feels that it's important to further investigate how research activity is being changed in response to dual-use concerns." With regard to future actions that the life sciences community would support to reduce the threat of misuse of research, the survey results indicate that life scientists in the U.S. may be more willing to consider mechanisms to reduce risks if they are developed and implemented by the scientific community itself. Most respondents favor their professional societies prescribing a code of conduct to help prevent misuse of life science research, for example, while a minority supported greater federal oversight. Among possible government restrictions, respondents were more supportive of restrictions on access to biological agents and certification of researchers than of any control of scientific knowledge generated from the research. In addition, respondents showed support for mandatory training by institutions for practicing life scientists regarding dual-use concerns, as well as education materials and lectures for students. The survey results also highlight the need to better define the scope of research that is of concern, the report notes. Fewer than half the respondents who reported carrying out dual-use research activities felt that their work falls into one of the seven categories of research of concern identified by the National Science Advisory Board for Biosecurity, which was created in 2004 to advise federal agencies about dual-use research. Based on the survey results, the committee urged further exploration of ways to provide guidance to the life sciences community about appropriate actions that could protect against misuse of dual-use research. The committee also recommended further research to examine the effectiveness of educational programs on these topics and find ways to enhance them. In addition, the report recommends surveys and interviews that can reach additional life scientists or begin to probe more deeply into life scientists' attitudes. And surveys of scientists outside the U.S. would increase knowledge and help facilitate international discussions of potential measures to address concerns about dual-use research. National Academy of Sciences |
|||||||||||||||||||||
| Related Bioterrorism Current Events and Bioterrorism News Articles Most would refuse emergency use H1N1 vaccine or additive A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. Nanoparticle treatment for burns curbs infection, reduces inflammation Treating second-degree burns with a nanoemulsion lotion sharply curbs bacterial growth and reduces inflammation that otherwise can jeopardize recovery, University of Michigan scientists have shown in initial laboratory studies. Toxin detection as close as an inkjet printer If that office inkjet printer has become just another fixture, it's time to take a fresh look at it. Similar technology may soon be used to develop paper-based biosensors that can detect certain harmful toxins that can cause food poisoning or be used as bioterrorism agents. Study Characterizes Eczema Patients Most at Risk for Dangerous Viral Infections Eczema patients at risk for serious viral infections have more severe disease, are more likely to be allergic to food and other allergens, and have a frequent history of staph infections. Scientists block Ebola infection in cell-culture experiments Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells. Milwaukee swine flu testing results published Researchers at The Medical College of Wisconsin in Milwaukee published the first initial paper describing the Milwaukee prevalence of the largest outbreak of novel swine origin influenza virus (S-OIV) in America. La Jolla Institute unlocks mystery of potentially fatal reaction to smallpox vaccine Researchers from the La Jolla Institute for Allergy & Immunology have pinpointed the cellular defect that increases the likelihood, among eczema sufferers, of developing eczema vaccinatum, a severe and potentially fatal reaction to the smallpox vaccine. Scientists discover how smallpox may derail human immune system University of Florida researchers have learned more about how smallpox conducts its deadly business - discoveries that may reveal as much about the human immune system as they do about one of the world's most feared pathogens. La Jolla Institute announces 2.0 launch of major database to aid vaccine development worldwide Key improvements in a major infectious disease database that will aid vaccine development worldwide were unveiled today with the 2.0 launch of the National Institutes of Health-sponsored Immune Epitope Database and Analysis Resource (IEDB). Study finds program has improved health agencies' preparedness for bioterror and disease outbreaks A federal program designed to help metropolitan public health agencies prepare to deliver essential medicines to the public after a large-scale bioterror attack or natural disease outbreak has succeeded in improving the level of readiness, according to a new RAND Corporation study. More Bioterrorism Current Events and Bioterrorism News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||